催化学报  2015, Vol. 36 Issue (7): 1124-1130   PDF (372 KB)    
扩展功能
加入收藏夹
复制引文信息
加入引用管理器
Email Alert
RSS
本文作者相关文章
Mahmoud. Abd
El Aleem. Ali
Ali. El-Remaily
Bismuth triflate: A highly efficient catalyst for the synthesis of bio-active coumarin compounds via one-pot multi-componentreaction
Mahmoud. Abd, El Aleem. Ali, Ali. El-Remaily     
Department of Chemistry, Faculty of Science, Sohag University- 82524, Sohag, Egypt
Abstract: A series of coumarin-chalcone hybrid compounds and coumarins linked to pyrazoline was synthesized in good yield and short time using a simple and efficient method. This method involved the one-pot reaction of salicylaldehyde, an α-ketoester and an aromatic aldehyde (in the case of the coumarin-chalcone derivatives) in addition to hydrazine hydrate (in the case of the pyrazolyl coumarins) in the presence of a catalytic amount of bismuth triflate [Bi(OTf)3, 5 mol%]. The synthesized compounds showed scavenging activity towards the free radical 2,2-diphenyl-1-picrylhydrazyl. All compounds were characterized using IR, 1H NMR and 13C NMR spectroscopy.
© 2015, Dalian Institute of Chemical Physics, Chinese Academy of Sciences.
Published by Elsevier B.V. All rights reserved.
Key words: Coumarin     Chalcone     Pyrazoline     One-pot multi-component reaction     Salicylaldehyde     α-Ketoester     Bismuth triflate [Bi(OTf)3]    

1. Introduction

The coumarin moiety is an important structural motif in natural products and highly bioactive compounds. Coumarin-containing compounds exhibit broad biological activity with, for example, antioxidant, anticoagulant, antifungal, anthelmintic, cytotoxic or hypnotic properties [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]. Because of their fluorescent properties, coumarins are also widely applied as agrochemicals; used in optical brighteners, cosmetics and food; and employed as scattered fluorescent and disciplined laser-dye optical agents [11, 12]. Chalcones, one of the major classes of natural products prevalent in fruits, vegetables, spices and soy-based foodstuffs, have been reported to have several biological properties [13, 14]. The chalcone moiety imparts biological activity upon the molecule, giving it, for example, anti-inflammatory [15], antifungal [16], antioxidant [17], antimalarial [18], antituberculosis [19], analgesic [20], anti-HIV [21] and antitumor [22] properties. Linking coumarins to pyrazoline rings may lead to compounds with important properties, as pyrazoline itself shows anti-inflammatory, antidiabetic, anesthetic, analgesic, and other potent selective activity, such as behavior as a nitric oxide synthase (NOS) inhibitor or a cannabinoid CB1 receptor antagonist [23].

Multi-component reactions (MCRs) are processes in which three or more reactants are joined in a single step to produce products that combine substantial portions of all the reactants [24, 25, 26, 27]. In recent years, MCRs have unfolded as a powerful tool for creating the substructures of novel and complex molecules due to their advantages over traditional multi-step synthesis. The major advantages of MCRs include their lower cost, shorter reaction time and high atom economy, lower energy requirements, and the avoidance of time consuming and expensive purification processes. MCRs are generally more eco-friendly than traditional syntheses, and offer fast access to wide libraries of compounds with different functionalities [28, 29, 30, 31, 32]. During recent years, Bi(III) salts have caught the attention of synthetic organic chemists as effective catalysts because of their low toxicity, eco friendliness, ease of handling, low cost and relative insensitivity to air and moisture [33, 34, 35, 36, 37, 38]. Among the Bi(III) salts, bismuth triflate [Bi(OTf)3] is the most efficient catalyst, and is particularly attractive because it is commercially available or easily prepared from commercially available starting materials [39, 40, 41, 42, 43, 44, 45, 46].

One of my aims in recent years has been the development of new tools and methodologies for the synthesis of heterocyclic compounds using an efficient catalyst. Following this aim I designed hybrid molecules based on naturally occurring compounds, coumarin-chalcone moieties and coumarines linked to pyrazolines, using multi-component reaction techniques in the presence of a catalytic amount (5 mol%) of the green catalyst Bi(OTf)3.

2. Experimental

All melting points were recorded on a Melt-Temp II melting point apparatus. IR spectra were measured as KBr pellets on a Shimadzu DR-8001 spectrometer. 1H NMR spectra were recorded on a Bruker DRX 300 or 400 MHz spectrometer using TMS as an internal reference and DMSO-d6 or CDCl3 as the solvent. The purity of all compounds was checked on thin layer chromatography (TLC) plates. All the synthesized compounds were prepared according to the method described by Sugino et al. [47] and Bhatnagar et al. [48]. Confirmation of the proposed structures of all prepared compounds by IR, 1HNMR and 13C NMR spectroscopy are also reported.

2.1. General procedure for the synthesis of 3-cinnamoyl coumarins (5a-5n)

Method A

In a 50 mL round bottom flask, salicylaldehyde 1 (1 mmol), methyl acetoacetate or ethyl acetoacetate 2 (1 mmol) and aromatic aldehyde 3 (1 mmol) were mixed in the presence of Bi(OTf)3 (5 mol%) in dichloromethane (DCM, 5 mL). The reaction mixture was stirred at 50 °C for a specified time. The progress of the reaction was monitored by TLC. The products precipitated rapidly after 15 to 30 min (see Table 2). The solid material was filtered off, washed with water, dried, and recrystallized from ethanol to furnish pure 3-cinnamoylcoumarin derivatives (5a-5n).

Method B

First step: Synthesis of 3-acetylcoumarin (4)

A mixture of salicylaldehyde (1 eq.), methyl acetoacetate or ethyl acetoacetate (1 eq.) and a few drops of piperidine were stirred at room temperature without any solvent. Precipitation occurred immediately. The compound was then recrystallized from ethanol [47]. Yield 89%; M.P. 119-121 °C; 1H NMR (300 MHz, CDCl3, δ/ppm) 8.34 (s, 1H), 7.54-7.42 (m, 2H), 7.26-7.12 (m, 2H), 2.56 (s, 3H).

Second step: Synthesis of 5a-5n

A mixture of 3-acetylcoumarin 4 (1 eq.) and the corresponding aldehyde (1.2 eq.) were mixed in the presence of Bi(OTf)3 (5 mol%) in DCM (5 mL). The reaction mixture was stirred at 50 °C for a specified time. The progress of the reaction was monitored by TLC. The products precipitated slowly after 4 h. The solid material was filtered off, washed with water, dried, and recrystallized from ethanol.

1-(3'-Coumarinyl)-3-phenyl-2-propen-1-one (5a). Yield 89%; M.P. 180-182 °C; IR (KBr, cm−1): 3037 (Ar, C-H str), 2968 (alkane, C-H str), 1714 (C=O), 1683 (C=O), 1610 (C=C); 1H NMR (CDCl3, δ/ppm): 8.61 (s, 1H, C-H), 7.90 (d, 1H, =CH), 7.71-7.54 (m, 4H, coumarin), 7.419-7.266 (m, 5H, Ar-H), 6.87 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 196.52, 161.23, 153.22, 147.36, 138.69, 133.25, 132.00, 130.78, 129.89, 129.14, 128.55, 127.19, 124.74, 124.10, 122.05, 114.36; Anal. Calc. for C18H12O3 (276.29): C 78.25%, H 4.38%; Found: C 78.17%, H 4.28%.

1-(3'-Coumarinyl)-3-(4″-methoxyphenyl)-2-propen-1-one

(5b). Yield 91%; M.P. 140-142 °C; IR (KBr, cm−1): 3052 (Ar, C-H str), 1705 (C=O), 1681 (C=O), 1604 (C=C str), 1612 (C=C ); 1H NMR (CDCl3, δ/ppm): 8.54 (s, 1H, C-H), 7.80 (d, 1H, =C-H), 7.68-7.63 (m, 4H, coumarin), 7.44-7.21(m, 4H, Ar-H), 6.91 (d, 1H, =C-H), 2.74 (s, 3H, O-CH3); 13C NMR (CDCl3, δ/ppm): 190.12, 162.20, 161.54, 154.79, 147.30, 138.89, 131.88, 130.07, 130.78, 128.84, 128.04, 127.14, 124.80, 124.09, 122.08, 114.36, 55.20; Anal. Calc. for C19H14O4 (306.32): C 74.50%, H 4.61%; Found: C 74.44%, H 4.58%.

1-(3'-Coumarinyl)-3-(4″-chlorophenyl)-2-propen-1-one

(5c). Yield 96%; M.P. 188-190 °C; IR (KBr, cm−1): 3031 (Ar, C-H str), 1715 (C=O), 1679 (C=O); 1610 (C=C); 1H NMR (CDCl3, δ/ppm): 8.59 (s, 1H, C-H), 7.98 (d, 1H, =C-H), 7.67-7.52 (m, 4H, coumarin), 7.41-7.26 (m, 4H, Ar-H), 6.84 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 194.50, 162.20, 154.77, 147.47, 138.78, 135.54, 134.11, 130.78, 129.98, 129.41, 128.05, 127.84, 124.64, 124.09, 122.07, 114.62; Anal. Calc. for C18H11O3Cl (310.74): C 69.58%, H 3.57%, Cl 11.41%; Found: C 69.55%, H 3.59%, Cl 11.09%.

1-(3'-Coumarinyl)-3-(2″-chlorophenyl)-2-propen-1-one

(5d). Yield 89%; M.P. 204-206 °C; IR (KBr, cm−1): 3054 (Ar, C-H str), 1721 (C=O), 1684(C=O), 1610 (C=C); 1H NMR (CDCl3, δ/ppm): 8.61 (s, 1H, C-H), 7.96 (d, 1H, =C-H), 7.70-7.65 (m, 4H, coumarin), 7.45-7.26 (m, 4H, Ar-H), 6.26 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 193.41, 162.13, 154.77, 143.44, 138.58, 134.04, 133.57, 130.87, 130.08, 129.94, 128.76, 128.14, 127.84, 127.04, 124.71, 124.13, 122.06, 114.60; Anal. Calc. for C18H11O3Cl (310.74): C 69.58%, H 3.57%, Cl 11.41%; Found: C 69.55%, H 3.59%, Cl 11.09%.

1-(3'-Coumarinyl)-3-(4″-hydroxyphenyl)-2-propen-1-one

(5e). Yield 91%; M.P. 176-178 °C; IR (KBr, cm−1): 3389 (OH), 3038 (Ar, C-H), 1702 (C=O), 1689 (C=O), 1612 (C=C); 1H NMR (CDCl3, δ/ppm): 9.73 (s, 1H, OH), 8.67 (s, 1H,C-H), 7.95 (d,1H, =C-H), 7.77-7.60 (m, 4H, coumarin), 7.50-7.32 (m, 4H, Ar-H), 6.86 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 189.18, 162.38, 161.74, 154.77, 147.32, 138.30, 131.54, 130.04, 128.17, 127.79, 127.09, 124.64, 124.09, 122.07, 116.41, 114.62; Anal. Calc. for C18H12O4 (292.29): C 73.97%, H 4.14%; Found: C 73.81%, H 4.11%.

1-(3'-Coumarinyl)-3-(2″-hydroxyphenyl)-2-propen-1-one

(5f). Yield 90%; M.P. 78-79 °C; IR (KBr, cm−1): 3412 (OH str), 3041 (Ar, C-H), 1712 (C=O), 1680 (C=O), 1610 (C=C); 1H NMR (CDCl3, δ/ppm): 9.67 (s, 1H, OH), 8.76 (s, 1H, C-H), 7.75 (d, 1H, =C-H), 7.48-7.42 (m, 4H, coumarin), 7.10-6.93 (m, 4H, Ar-H), 6.64 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 191.47, 162.10, 154.79, 143.04, 138.78, 134.14, 133.47, 130.37, 130.08, 129.91, 128.74, 128.14, 127.84, 127.04, 124.71, 124.13, 122.06, 114.62; Anal. Calc. for C18H12O4 (292.29): C 73.97%, H 4.14%; Found: C 73.81%, H 4.11%.

1-(3'-Coumarinyl)-3-(2″-furyl)-2-propen-1-one (5g). Yield 89%; M.P. 101-103 °C; IR (KBr, cm−1): 3037 (Ar, C-H), 1716 (C=O), 1680 (C=O), 1608 (C=C); 1H NMR (CDCl3, δ/ppm): 8.58 (d, 1H, =C-H), 7.83 (d, 1H, =C-H), 7.70-7.60 (m, 4H, coumarin), 7.45-7.34 (m, 3H, furyl), 6.85 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 188.40, 162.65, 154.79, 151.32, 145.00, 138.84, 133.40, 130.07, 127.69, 125.61, 125.04, 124.54, 122.44, 120.32, 114.74, 106.47; Anal. Calc. for C16H10O4 (266.25): C 72.18%, H 3.79%; Found: C 72.01%, H 3.61%.

1-(3'-Coumarinyl)-3-(2″,4″,6″-trimethoxyphenyl)-2-propen-1-one (5h). Yield 89%; M.P. 158-160 °C; IR (KBr, cm−1): 3045 (Ar, C-H ), 1720 (C=O), 1680 (C=O), 1610 (C=C); 1H NMR (CDCl3, δ/ppm): 8.61 (s, 1H, C-H), 7.89 (d, 1H, =C-H), 7.78-7.60 (d, 4H, coumarin), 7.44-7.32 (s, 2H, Ar-H), 6.92 (d, 1H, =C-H), 3.94 (s, 9H, 3OCH3); 13C NMR (CDCl3, δ/ppm): 189.10, 162.38, 161.74, 161.05, 154.78, 147.29, 138.82, 130.04, 127.65, 126.78, 124.64, 124.19, 122.04, 114.66, 105.27, 90.81, 55.64, 55.18; Anal. Calc. for C21H18O6 (366.37): C 68.85%, H 4.95%; Found: C 68.80%, H 4.91%.

1-(3'-Coumarinyl)-3-(3″,5″-dimethoxyphenyl)-2-propen-1-one (5i). Yield 88%; M.P. 147-149 °C; IR (KBr, cm−1): 3026 (Ar, C-H), 1722(C=O), 1685 (C=O), 1606 (C=C); 1H NMR (CDCl3, δ/ppm): 8.61 (s, 1H, C-H), 7.89 (d, 1H, =C-H), 7.78-7.60 (d, 4H, coumarin), 7.44-7.36 (s, 3H, Ar-H), 6.84 (d, 1H, =C-H), 3.90 (s, 6H, 2OCH3);13C NMR (CDCl3, δ/ppm): 188.19, 162.65, 161.45, 154.84, 147.58, 138.83, 137.33, 130.04, 128.08, 127.69, 124.78, 124.14, 122.02, 114.74, 109.81, 100.04, 55.63; Anal. Calc. for C20H16O5 (336.34): C 71.42%, H 4.79%; Found: C 71.50%, H 4.63%.

1-(3'-Coumarinyl)-3-(4″-dimethylaminophenyl)-2-propen-1-one (5j). Yield 89%; M.P. 108-110 °C; IR (KBr, cm−1): 3035 (Ar, C-H), 1714 (C=O), 1681 (C=O), 1606 (C=C); 1H NMR (CDCl3, δ/ppm): 8.58 (s, 1H, C-H), 7.92 (d, 1H, =C-H), 7.77-7.66 (m, 4H, coumarin), 7.66 (d, 2H, Ar-H), 7.44 (d, 1H, =C-H), 6.72 (d, 2H, Ar-H), 3.07 (s, 6H, 2CH3); 13C NMR (CDCl3, δ/ppm): 188.51, 162.65, 154.77, 151.10, 147.23, 138.83, 131.29, 130.04, 128.07, 127.78, 124.64, 124.54, 123.47, 122.02, 114.71, 112.02, 39.71; Anal. Calc. for C20H17NO3 (319.36): C 75.22%, H 5.37%, N 4.39%; Found: C 75.02%, H 5.29%, N 4.20%.

1-(3'-Coumarinyl)-3-(4″-fluorophenyl)-2-propen-1-one

(5k). Yield 88%; M.P. 171-173 °C; IR (KBr, cm−1): 3031 (Ar, C-H), 1718 (C=O), 1666 (C=O), 1612 (C=C); 1H NMR (CDCl3, δ/ppm): 8.59 (s, 1H, C-H), 7.98 (d, 1H, =C-H), 7.67-7.52 (m, 4H, coumarin), 7.41-7.26 (m, 4H, Ar-H), 6.84 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 191.50, 162.20, 154.27, 147.47, 138.38, 135.78, 134.01, 130.78, 129.78, 129.21, 128.07, 127.64, 124.64, 124.06, 122.04, 114.60; Anal. Calc. for C18H11O3F (295.29): C 73.22%, H 4.10%, F 6.43%; Found: C 73.35%, H 4.03%, F 6.29%.

1-(3'-Coumarinyl)-3-(4″-bromophenyl)-2-propen-1-one

(5l). Yield 89%; M.P. 189-191 °C; IR (KBr, cm−1): 3034 (Ar, C-H), 1710 (C=O),1680 (C=O), 1610 (C=C); 1H NMR (CDCl3, δ/ppm): 8.57 (s, 1H, C-H), 7.90 (d, 1H, =C-H), 7.71-7.50 (m, 4H, coumarin), 7.40-7.16 (m, 4H, Ar-H), 6.59 (d, 1H,=C-H); 13C NMR (CDCl3, δ/ppm): 190.44, 162.24, 154.27, 147.47, 138.47, 135.66, 134.04, 130.78, 129.78, 129.21, 128.07, 127.64, 124.64, 124.10, 122.02, 114.60; Anal. Calc. for C18H11O3Br (356.19): C 60.70%, H 3.40%, Br 22.43%; Found: C 60.63%, H 3.98%, Br 22.20%.

1-(3'-Coumarinyl)-3-(4″-nitrophenyl)-2-propen-1-one

(5m). Yield 89%; M.P. 154-156 °C; IR (KBr, cm−1): 3045 (Ar, C-H), 1714 (C=O), 1678 (C=O), 1611 (C=C); 1H NMR (CDCl3, δ/ppm): 8.74 (s, 1H, C-H), 7.65 (d, 1H, =C-H), 7.55-7.48 (m, 4H, coumarin), 7.37-7.20 (m, 4H, Ar-H), 6.56 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 190.50, 162.20, 154.27, 147.47, 138.38, 135.78, 134.01, 130.78, 129.78, 129.21, 128.07, 127.64, 124.64, 124.06, 122.04, 114.60; Anal. Calc. for C18H11O5N (321.29): C 67.29%, H 3.45%, N 4.36%; Found: C 67.31%, H 3.38%, N 4.22%.

1-(3'-Coumarinyl)-3-(3″-nitrophenyl)-2-propen-1-one (5n). Yield 88%; M.P. 205-207 °C; IR (KBr, cm−1): 3030 (Ar, C-H), 1710 (C=O), 1683 (C=O), 1610 (C=C); 1H NMR (CDCl3, δ/ppm): 8.97 (s, 1H, C-H), 7.87 (d, 1H, =C-H), 7.65-7.49 (m, 4H, coumarin), 7.44-7.21 (m, 4H, Ar-H), 6.68 (d, 1H, =C-H); 13C NMR (CDCl3, δ/ppm): 188.51, 162.65, 154.84, 149.57, 147.25, 138.89, 138.28, 135.19, 130.88, 130.08, 128.24, 127.67, 125.61, 124.54, 122.02, 121.64, 114.47; Anal. Calc. for C18H11O5N (321.29): C 67.29%, H 3.45%, N 4.36%; Found: C 67.31%, H 3.38%, N 4.22%.

2.2. General procedure for the synthesis of pyrazolyl coumarins (7a-7h) [35]

A mixture of salicylaldehyde 1 (1 mmol), methyl acetoacetate or ethyl acetoacetate 2 (1 mmol), aromatic aldehyde 3 (1 mmol) and hydrazine hydrate 6 (1 mmol) were mixed in the presence of Bi(OTf)3 (5 mol%) in DCM (5 mL). The reaction mixture was stirred at 50 °C for the specified time (see Table 3). The progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was allowed to stand overnight. The solid material was filtered off, washed with water, dried, and recrystallized from ethanol to furnish pure pyrazolyl coumarin derivatives.

3-(4,5-Dihydro-5-(4-methoxyphenyl)-1H-pyrazol-3-yl)-2H-chromen-2-one (7a). Yield 90%; M.P. 183-185 °C; IR (KBr; cm-1): 1634 (C=N), 3268 (Ar N-H), 1172 (-OCH3); 1H NMR (CDCl3, δ/ppm): 6.72-7.27 (m, 13H, Ar), 7.46 (s, 1H, coumarin), 4.80 (d, 1H, 5-H of pyrazoline), 3.301 (d, 1H, 4-Htrans of pyrazoline), 3.305 (d, 1H, 4-Hcis of pyrazoline), 3.73 (s, 3H, -OCH3); Anal. Calc. for C19H16O3N2: C 71.24%, N 8.74%; Found: C 70.68%, N 8.55%.

3-(4,5-dihydro-5-(2-methoxyphenyl)-1H-pyrazol-3-yl)-2H-

chromen-2-one (7b). Yield 88%; M.P. 166-168 °C; IR (KBr; cm-1): 1554 (C=N), 3245 (ArN-H); 1H NMR (CDCl3/DMSO-d6, δ/ppm): 6.72-7.27 (m, 13H, Ar), 7.65 (s, 1H, coumarin), 4.82 (d, 1H, 5-H of pyrazoline), 3.23 (d, 1H, 4-Htrans of pyrazoline), 3.30 (d, 1H, 4-Hcis of pyrazoline), 3.73 (s, 3H, -OCH3); Anal. Calc. for C19H16O3N2: C 71.24%, N 8.74%; Found: C 70.85%, N 8.34%.

3-(5-(4-Chlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2H-

chromen-2-one (7c). Yield 95%; M.P. 175-177 °C; IR (KBr; cm-1): 1622 (C=N), 3282 (ArN-H), 1091 (Ar-Cl); 1H NMR (CDCl3/DMSO-d6, δ/ppm): 7.01-7.28 (m, 13H, Ar), 7.40 (s, 1H, coumarin), 5.01 (d, 1H, 5-H of pyrazoline), 3.30 (d, 1H, 4-Htrans of pyrazoline), 3.33 (d, 1H, 4-Hcis of pyrazoline); Anal. Calc. for C18H13ClO2N2: C 66.57%, N 8.63%; Found: C 66.43%, N 8.27%.

3-(5-(4-Fluorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2H-

chromen-2-one (7d): Yield 91%; M.P. 180-182 °C; IR (KBr; cm-1): 1634 (C=N), 3268 (Ar N-H), 1042 (Ar C-F); 1H NMR (CDCl3/DMSO-d6, δ/ppm): 6.813-7.5 (m, 13H, Ar), 7.49 (s, 1H, coumarin), 4.86 (d, 1H, 5-H of pyrazoline), 3.25 (d, 1H, 4-Htrans of pyrazoline), 3.307 (d,1H, 4-Hcis of pyrazoline); Anal. Calc. for C18H13FO2N2. C 70.12%, N 9.09%; Found: C 69.86%, N 9.13%.

3-(5-(4-Bromophenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2H-

chromen-2-one (7e). Yield 89%; M.P. 176-178 °C; IR (KBr; cm-1): 1623.53 (C=N), 3257 (Ar N-H), 658 (C-Br); 1H NMR (CDCl3/DMSO-d6, δ/ppm): 7.01-7.38 (m, 13H, Ar), 7.46 (s, 1H, coumarin), 4.89 (d, 1H, 5-H of pyrazoline), 3.28 (d, 1H, 4-Htrans of pyrazoline), 3.33 (d, 1H, 4-Hcis of pyrazoline); Anal. Calc. for C18H13BrO2N2. C 58.56%, N 7.59%; Found: C 59.02%, N 7.11%.

3-(4,5-dihydro-5-(4-nitrophenyl)-1H-pyrazol-3-yl)-2H-chromen-2-one (7f): Yield 86%; M.P. 199-201 °C; IR (KBr; cm-1): 1558 (C=N), 3234 (Ar N-H), 1519 (Symmt =N-O of NO2), 1340 (Asymmt =N-O of NO2); 1H NMR (CDCl3/DMSO-d6, δ/ppm): 7.02-8.14 (m, 13H, Ar), 7.46 (s, 1H, coumarin), 4.86 (d, 1H, 5-H of pyrazoline), 3.301 (d, 1H, 4-Htrans of pyrazoline), 3.305 (d, 1H, 4-Hcis of pyrazoline); Anal. Calc. for C18H13O4N3: C 64.47%, N 12.53%; Found: C 64.30%, N 12.81%.

3-(4,5-Dihydro-5-(3-nitrophenyl)-1H-pyrazol-3-yl)-2H-

chromen-2-one (7g). Yield 87%; M.P. 189-190 °C; IR (KBr; cm-1): 1622 (C=N), 3274 (Ar N-H), 1488 (Symmt =N-O of NO2), 1350 (Asymmt=N-O of NO2); 1H NMR (CDCl3/DMSO-d6, δ/ppm): 6.90-8.07 (m, 13H, Ar), 7.49 (s, 1H, coumarin), 4.86 (d, 1H, 5-H of pyrazoline), 3.30 (d, 1H, 4-Htrans of pyrazoline), 3.33 (d, 1H, 4-Hcis of pyrazoline); Anal. Calc. for C18H13O4N3: C 64.47%, N 12.53%; Found: C 64.52%, N 11.98%.

3-(4,5-Dihydro-5-p-tolyl-1H-pyrazol-3-yl)-2H-chromen-2-

one (7h). Yield 90%; M.P. 160-162 °C; IR (KBr; cm-1): 1620 (C=N), 3284 (ArN-H); 1H NMR (CDCl3/DMSO-d6, δ/ppm): 7.00-7.27 (m, 13H, Ar), 7.42 (s, 1H, coumarin), 4.55 (d, 1H, 5-H of pyrazoline), 3.29 (d, 1H, 4-Htrans of pyrazoline), 3.31 (d, 1H, 4-Hcis of pyrazoline), 2.35 (s, 3H, CH3); Anal. Calc. for C19H16O2N2 C 74.98%, N 9.20%; Found: C 73.84%, N 8.56%.

3. Results and discussion
3.1. The reaction conditions

Initially, the synthesized compounds 5a-5n were obtained from the three-component reaction of salicylaldehyde, an α-ketoester (methyl acetoacetate or ethyl acetoacetate) and various aromatic aldehydes in DCM with the addition of a catalytic amount of the green catalyst Bi(OTf)3 (5 mol%) (Scheme 1).

Scheme 1. Synthesis of 3-cinnamoyl coumarin derivatives (5a-5n).

The optimization of the reaction conditions was then studied for 5c. No product was obtained from the reaction of salicylaldehyde, ethyl acetoacetate and 4-chlorobenzaldehyde in the absence of the catalyst at 50 °C in DCM (Table 1, entry 1). The reaction was then performed in the presence of various simple metal complexes such as those of Fe, Zn, Mg and Cu to examine their catalytic activity (Table 1, entries 2-9). Among these metal salts (5 mol%), Bi(OTf)3 was found to be the most effective catalyst and afforded the desired product 5c in 96% yield (Table 1, entry 11). When using methanol (MeOH), N,N- dimethylformamide (DMF), toluene (PhCH3) and acetonitrile (CH3CN) instead of DCM, relatively lower yields were observed (Table 1, entries 16-19). The desired products were rapidly precipitated in good yield on warming for 15-30 min (see Table 2).

Table 1
Optimization of the conditions for the synthesis of 5c.

Table 2
Reaction time for the synthesis of 5a-5n using a one-pot reaction protocol.

Compounds 7a-7h were synthesized using a one-pot four-component reaction between salicylaldehyde, an α-ketoester (methyl acetoacetate or ethyl acetoacetate), several aromatic aldehydes and hydrazine hydrate in DCM under the same conditions used for the synthesis of 5. The products were precipitated after cooling for 2-4 h (see Table 3 and Scheme 2).

Scheme 2. Synthesis of coumarins linked to pyrazoline.

Table 3
Reaction time for the synthesis of 7a-7h using the one-pot reaction protocol.

To gain further insights into the reaction, products 5a-5n were synthesized in two steps. In the first step, the precursor 3-acetylcoumarin 4 was prepared by a Knoevenagel reaction between salicylaldehyde and an α-ketoester (methyl acetoacetate or ethyl acetoacetate) under basic conditions in 89% yield [47, 48]. In the second step, 4 was reacted with various aromatic aldehydes to give the final products 5a-5n by a Claisen-Schmidt aldolic condensation. Under the same conditions as those used in the one-pot reaction, these reactions take a long time and have low yields. The same result was also seen for products 7a-7h, which wereobtained from coumarin-chalcone compounds with hydrazine hydrate (Scheme 3).

Scheme 3. Control experiments for the synthesis of 5c and 7c in a stepwise reaction.
3.2. DPPH radical scavenging assay

The 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay was based on the reported method [49, 50]. A rapid, simple and inexpensive method to measure antioxidant capacity of substances involves the use of the free radical, DPPH. DPPH is widely used to test the ability of compounds to act as free radical scavengers or hydrogen donors. Antioxidants tested on DPPH were also found extremely effective in cell systems. This simple test further provides information on the ability of a compound to donate electrons during antioxidant action [51]. The radical scavenging mechanism is based on the transfer of acidic H-atom from the compound to DPPH radical to form DPPH-H.

A DMSO sample of the compounds at 50 μg/mL was diluted to 4 mL using MeOH. To this, 1 mL of DPPH solution in MeOH was added. The mixed solution was incubated at room temperature for 30 min. The absorbance of stable DPPH was determined at 517 nm using UV/Vis spectroscopy, and the remaining amount of DPPH was calculated. Ascorbic acid (50 μg/mL) was used as a standard. The free radical scavenging activity was expressed as follows:

DPPH scavenging activity (%) = [Ac−As] / [Ac−Ab] × 100

where Ac,As and Ab are the absorbance of the control, the sample and the blank (MeOH+DMSO), respectively. Each sample was assayed at 50 μg/mL and all experiments were carried out in triplicate. The radical scavenging activity is shown in Table 4.

Table 4
DPPH radical scavenging assay of compounds 7a-7h.
4. Conclusions

The synthesis of potential bio-active hybrid molecules obtained from naturally occurring coumarin-chalcone moieties and coumarins linked to pyrazoline using Bi(OTf)3 as a highly efficient catalyst has been achieved using a one-pot multi-component reaction protocol. This method has the advantages of low cost, short reaction time, high atom economy, convenience and efficiency. It also offers a selective approach to the synthesis of coumarins, a structural motif found in a large number of natural products, pharmaceuticals and functionalized materials. Such a selective procedure offers energy saving advantages and reduces the expense of the purification process. The synthesized compounds showed DPPH scavenging activity. Applications of this protocol to the selective synthesis of bioactive molecules are in progress in our research group.

Acknowledgments

The author expresses his deep gratitude to Sohag University in Egypt for supporting and facilitating this study.

References
[1] Sethna S M, Shah N M. Chem Rev, 1945, 36: 1
[2] Riveiro M E, De Kimpe N, Moglioni A, Vazquez R, Monczor F, Shayo C, Davio C. Curr Med Chem, 2010, 17: 1325
[3] Riveiro M E, Maes D, Vazquez R, Vermeulen M, Mangelinckx S, Jacobs J, Debenedetti S, Shayo C, De Kimpe N, Davio C. Bioorg Med Chem, 2009, 17: 6547
[4] O’Kennedy R, Thornes R D. Coumarins: Biology, Applications, and Mode of Action. Chichester (UK): Wiley, 1997
[5] Yu D L, Suzuki M, Xie L, Morris-Natschke S L, Lee K H. Med Res Rev, 2003, 23: 322
[6] Zhang Q Y, Qin L P, He W D, Van Puywelde L, Maes D, Adams A, De Kimpe N. Planta Medica, 2007, 73: 13
[7] Riveiro M E, Shayo C, Monczor F, Fernandez N, Baldi A, De Kimpe N, Rossi J, Debenedetti S, Davio C. Cancer Lett, 2004, 210: 179
[8] Murray R D H, Mendez J, Brown S A. The Natural Coumarins: Occurrence, Chemistry, and Biochemistry. Chichester (UK): Wiley, 1982
[9] Nguyen V T, Debenedetti S, De Kimpe N. Tetrahedron Lett, 2003, 44: 4199
[10] Maes D, Vervisch S, Debenedetti S, Davio C. Mangelinckx S, Giubellina N, De Kimpe N. Tetrahedron, 2005, 61: 2505
[11] Ngameni B, Watchueng J, Boyom F F, Keumedjio F, Ngadjui B T, Gut J, Abegaz B M, Rosenthal P J. ARKIVOC, 2007: 116
[12] Okwu D E, Ukanwa N. Chem Sin, 2010, 1(2): 21
[13] Ballesteros J F, Sanz M J, Ubeda A, Miranda M A, Iborra S, Paya M, Alcaraz M. J Med Chem, 1995, 38: 2794
[14] Go M L, Wu X, Liu X L. Curr Med Chem, 2005, 12: 483
[15] Mukherjee S, Kumar V, Prasad A K, Raj H G, Bracke M E, Olsen C E, Jain S C, Parmar V S. Bioorg Med Chem, 2001, 9: 337
[16] Liu M, Wilairat P, Croft S L, Tan A L G, Go M L. Bioorg Med Chem, 2003, 11: 2729
[17] Sivakumar P M, Babu S K G, Mukesh D. Chem Pharm Bull, 2007, 55: 44
[18] Viana G S B, Bandeira M A M, Mantos F J A. Phytomedicine, 2003, 10: 189
[19] Xia Y, Yang Z Y, Xia P, Bastow K F, Nakanishi Y, Lee K H. Bioorg Med Chem lett, 2000, 10: 699
[20] Ducki S, Forrest R, Hadfield J A, Kendall A, Lawrence N J, McGown A T, Rennison D. Bioorg Med Chem Lett, 1998, 8: 1051
[21] Wagner B D. Molecules, 2009, 14: 210
[22] Dorlars A, Schellhammer C W, Schroeder J. Angew Chem Int Ed, 1975, 14: 665
[23] Kumar S, Bawa S, Drabu S, Kumar R, Gupta H. Recent Patents on Anti-Infective Drug Discovery, 2009, 4: 154
[24] Zhu J P, Bienayme H. Multicomponent Reactions. Weinheim: WILEY-VCH, 2005
[25] Tejedor D, Garcia-Tellado F. Chem Soc Rev, 2007, 36: 484
[26] Ugi I. Pure Appl Chem, 2001, 73: 187
[27] Lieby-Muller F, Simon C, Constantieux T, Rodriguez, J. QSAR Comb Sci, 2006, 25: 432
[28] Trost B M. Angew Chem Int Ed, 1995, 34: 259
[29] Wender P A, Handy S T, Wright D L. Chem Ind, 1997: 767
[30] Weber L. Curr Opin Chem Biol, 2000, 4: 295-302
[31] El-Remaily M A A. Tetrahedron, 2014, 70: 2971
[32] Domling A. Curr Opin Chem Biol, 2002, 6: 306
[33] Leonard N M, Wieland L C, Mohan R S. Tetrahedron, 2002, 58: 8373
[34] Thirupathi P, Kim S S. Tetrahedron, 2009, 65: 5168
[35] Rivera S, Bandyopadhyay D, Banik B K. Tetrahedron Lett, 2009, 50: 5445
[36] Antoniotti S, Dunach E. C R Chim, 2004, 7: 679
[37] Mohammadpoor-Baltork I, Khosropour A R, Moghadam M, Tangestaninejad S, Mirkhani V, Baghersad S, Mirjafari A. C R Chim, 2011, 14: 944
[38] Wang Z Z, Fang S Y. Eur J Org Chem, 2009: 5505
[39] Ollevier T. Org Biomol Chem, 2013, 11: 2740
[40] Ollevier T. Top Curr Chem, 2012, 311: 69
[41] Pin F, Comesse S, Garrigues B, Marchaln S, Daich A. J Org Chem, 2007, 72: 1181
[42] Anzalone P W, Baru A R, Danielson E M, Hayes P D, Nguyen M P, Panico A F, Smith R C, Mohan R S. J Org Chem, 2005, 70: 2091
[43] Rueping M, Nachtsheim B J, Ieawsuwan W. Adv Synth Catal, 2006, 348: 1033
[44] Ollevier T, Li Z Y. Adv Synth Catal, 2009, 351: 3251
[45] Venkat Narsaiah A, Reddy B V S, Premalatha K, Reddy S S, Yadav J S. Catal Lett, 2009, 131: 480
[46] Podgorski D M, Krabbe S W, Le L N, Sierszulski P R, Mohan R S. Synthesis, 2010: 2771
[47] Sugino T, Tanaka K. Chem Lett, 2001, 30: 110
[48] Bhatnagar A, Sharma P K, Kumar N, Upadhyay A. Pharm Chem J, 2012, 46: 482
[49] Blois M S. Nature, 1958, 181: 1199
[50] Samshuddin S, Narayana B, Sarojini B K, Yathirajan H S, Raghavendra R. Pharm Chem, 2012, 4: 1445
[51] Tiwari A K. Curr Sci, 2004, 86: 1092"